Search our news archive and pharma companies…
|
Today's News | Note: News feeds may no longer be available for the articles on this page.
Novartis
gets FDA approval for blood pressure drug 3:39 PM 9/17/2009
Forbes
The US FDA approved Novartis' Valturna (valsartan and aliskiren) to treat
high blood pressure.
...
Generic
drugmakers criticize US health plan rebates 2:50 PM 9/17/2009
Reuters
About 70 percent of prescriptions dispensed in the US are filled with generics.
State-federal Medicaid program rate is only 64 percent. Medicaid could save almost $1 billion annually if they
caught up.
...
Drug
Stocks Advance; Sequenom Jumps On Launch 10:12 AM 9/17/2009
Wall Street Journal
Sequenom Inc shares jumped after the biotech group announced it launched its
new carrier screening test for cystic fibrosis.
...
Glaxo,
XenoPort Pain Drug Meets Endpoints Of Midstage Trial 7:19 AM 9/17/2009
Wall Street
Journal
GlaxoSmithKline PLC and XenoPort Inc's midstage trial of pain drug meets endpoint of
decreasing pain intensity.
...
US
FDA says no new warnings on Biogen, Elan MS drug 7:52 PM 9/16/2009
Reuters
Thirteen cases of progressive multifocal leukoencephalopathy (PML) have
been confirmed in MS patients treated with Tysabri as a stand-alone therapy. Biogen Idec and Elan Corp drug does
not need new warnings.
...
US
FDA panel backs Auxilium hand disorder drug 4:36 PM 9/16/2009
Reuters
US FDA advisors recommended Auxilium Pharmaceuticals Inc's drug Xiaflex to
treat Dupuytren's disease in which connective tissue in the hands hardens and contracts.
...
Hepatitis
B vaccine reduces liver cancer cases 3:25 PM 9/16/2009
Los Angeles Times
A study found cases of liver cancer have dropped significantly in children who
received the hepatitis B vaccine.
...
Baxter
says ramps up swine flu vaccine yields 2:07 PM 9/16/2009
Reuters
Baxter International Inc said its production yields of a "swine flu" vaccine have
increased three-fold as the company begins shipping.
...
Keryx
cancer drug gets orphan drug status; shares
soar 9:05 AM 9/16/2009
Reuters
Keryx
Biopharmaceuticals Inc said its experimental cancer drug KRX-0401 (perifosine) received orphan drug designation
from the US FDA.
...
Cell
Therapeutics posts follow-up cancer drug data 9:04 AM 9/16/2009
Forbes
Cell Therapeutics Inc said an extended review of its cancer drug candidate
pixantrone showed that patients were more likely to have a complete remission and live longer.
...
FDA approves 4 swine flu
vaccines 7:23 AM 9/16/2009
Bizjournals.com
The US FDA
has approved four different vaccines against H1N1 influenza virus. Injectable vaccines made by Switzerland’s
Novartis, Australia’s CSL Ltd, France’s Sanofi-Pasteur, and inhalable vaccine made by MedImmune in the US.
...
Savient:
FDA does not see more trials for gout drug 6:16 AM 9/16/2009
Reuters
Savient Pharmaceuticals said the US FDA does not expect additional trials
to be required for its experimental gout drug Krystexxa. The FDA cited CMC deficiencies.
...
Glaxo
Executive's Memo Suggested Burying Drug Studies 3:43 PM 9/15/2009
Bloomberg
Glaxo officials accused of urging scientists to withhold information
about Paxil’s risks from a paper laying out the company’s core safety philosophy.
...
Sanofi-Aventis:
FDA Approves Sanofi-Pasteur H1N1 Vaccine 2:49 PM 9/15/2009
Wall Street Journal
Sanofi-Aventis vaccine division Sanofi Pasteur said the US FDA
has licensed its pandemic influenza vaccine. Other companies have their vaccines approved.
...
Lexicon's
diabetes drug trial shows promise; shares soar 11:56 AM 9/15/2009
Forbes
Lexicon Pharmaceuticals said its orally-delivered drug LX4211 to treat type
2 diabetes showed positive results in an early-stage trial.
...
<- Day Earlier | Today's News
|
